AlkhalidYDarjiZShenkarR, et al. Multidisciplinary coordinated care of hereditary hemorrhagic telangiectasia (Osler-Weber-Rendu disease). Vasc Med2023; 28: 153–165.
3.
EswaranHKasthuriRS.Potential and emerging therapeutics for HHT. Hematology Am Soc Hematol Educ Program2024; 2024: 724–727.
4.
ZhangEVirkZMRodriguez-LopezJAl-SamkariH.Hereditary hemorrhagic telangiectasia may be the most morbid inherited bleeding disorder in women. Blood Adv2024; 8: 3166–3172.
5.
DroegeFThangaveluKStuckBA, et al. Life expectancy and comorbidities in patients with hereditary hemorrhagic telangiectasia. Vasc Med2018; 23: 377–383.
6.
PlauchuHde ChadarévianJPBideauARobertJM.Age-related clinical profile of hereditary hemorrhagic telangiectasia in an epidemiologically recruited population. Am J Med Genet1989; 32: 291–297.
7.
MacCarrickGRatchfordEV.Vascular Disease Patient Information Page: Genetic testing for inherited vascular diseases associated with aneurysm and dissection. Vasc Med2023; 28: 618–622.
8.
KilianAClancyMSOlitskyS, et al. Screening for pulmonary and brain vascular malformations is the North American standard of care for patients with hereditary hemorrhagic telangiectasia (HHT): A survey of HHT Centers of Excellence. Vasc Med2021; 26: 53–55.
9.
ChaturvediSClancyMSchaeferN, et al. Depression and post-traumatic stress disorder in individuals with hereditary hemorrhagic telangiectasia: A cross-sectional survey. Thromb Res2017; 153: 14–18.
